cAMP-dependent protein kinase and proliferation differ in normal and polycystic kidney epithelia

American Journal of Physiology - Cell Physiology

Volumn 282, Issue 4 51-4, 2002, Pages

  Marfella Scivittaro, Carmela ^a,b   Quiñones, Andrea ^a,b   Orellana, Stephanie A ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Case Western Reserve University ^*  (United States)

Author keywords

Epidermal growth factor receptor; Immunolocalization; Polycystic kidney disease; Protein kinase subtypes

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME SUBUNIT; IMMUNOLOCALIZATION; KIDNEY EPITHELIUM; KIDNEY POLYCYSTIC DISEASE; MOUSE; NONHUMAN; PATHOGENESIS; POLARIZATION; PREDICTION; PRIORITY JOURNAL;

ANIMALIA;

EID: 0036083611     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00122.2001     Document Type: Article

References (78)

1. Renal developmental diseases
2. Role of N-myc in the developing mouse kidney
3. Nephritogenic ochratoxin A interferes with hormonal signalling in immortalized human kidney epithelial cells
4. Co-regulation of antigen-specific T lymphocyte responses by type I and type II cyclic AMP-dependent protein kinases (cAK)
5. Cloned, stably expressed parathyroid hormone (PTH)/PTH-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells
6. Identification of cAMP-dependent protein kinase holoenzymes in preantral- and preovulatory-follicle-enriched ovaries, and their association with A-kinase-anchoring proteins
7. Compartmentalization of cAMP signaling in mesangial cells by phospho-diesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis
8. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A anti-sense oligonucleotide
9. Interactions between the epidermal growth factor receptor and type I protein kinase A: Biological significance and therapeutic applications
10. Inhibition of intracellular cAMP-dependent protein kinase using mutant genes of the regulatory type I subunit
11. AKAPs: From structure to function
12. Cyclic AMP signalling and cellular proliferation: Regulation of CREB and CREM
13. CL-387,785: An irreversible inhibitor of epidermal growth factor receptor tyrosine kinase with in vivo activity
14. Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney
15. Activation of cyclic AMP-dependent kinase is required but may not be sufficient to mimic cyclic AMP-dependent DNA synthesis and thyroglobulin expression in dog thyroid cells
16. A-kinase anchoring proteins: Protein kinase A and beyond
17. Molecular cloning, chromosomal localization, and cell cycle-dependent subcellular distribution of the A-kinase anchoring protein, AKAP95
18. Mating, channels, and kidney cysts
19. Cyclic nucleotide-dependent protein kinases: Intracellular receptors for cAMP and cGMP action
20. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action
21. Chemical modification of cell proliferation and fluid secretion in renal cysts
22. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells
23. Cyclic-AMP-dependent protein kinase (PKA) in testicular cells. Cell specific expression, differential regulation and targeting of subunits of PKA
24. Isoproterenol inhibits fibroblast growth factor-2-induced growth of renal epithelial cells
25. Mitosis-specific phosphorylation and subcellular redistribution of the RIIalpha regulatory subunit of cAMP-dependent protein kinase
26. Proliferation of adult rat hepatocytes by hepatocyte growth factor is potentiated by both phenylephrine and metaproterenol
27. Protein kinase A anchoring proteins are required for vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells
28. Mitogenic action of lysophosphatidic acid in proximal tubular epithelial cells obtained from voided human urine
29. Identification of phosphorylation sites in the PKD1-encoded protein C-terminal domain
30. Renal epithelial cyst formation and enlargement in vitro: Dependence on cAMP
31. Renal epithelial fluid secretion and cyst growth: The role of cyclic AMP
32. Trimeric G proteins modulate the dynamic interaction of PKAII with the Golgi complex
33. Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folk acid
34. Morphogenetic clonal growth of kidney epithelial cell line MDCK
35. New insights into the molecular pathophysiology of polycystic kidney disease
36. The molecular biology of polycystic kidney disease
37. Proliferative activity of cyst epithelium in human renal cystic diseases
38. 3-Chloroadenosine 3′,5′-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts
39. Cystic maldevelopment of the kidney
40. Cell and molecular biology of kidney development
41. Distinctive cyclic AMP-dependent protein kinase subunit localization is associated with cyst formation and loss of tubulogenic capacity in Madin Darby canine kidney cell clones
42. Novel Madin Darby canine kidney cell clones exhibit unique phenotypes in response to morphogens
43. Epidermal growth factor receptor expression is abnormal in murine polycystic kidney
44. Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: Role of protein kinase A in vascular smooth muscle cell mitogenesis
45. Identification of the major site of in vitro PKA phosphorylation in the polycystin-1 C-terminal cytosolic domain
46. The guanine nucleotide exchange factor CNras-GEF activates ras in response to cAMP and cGMP
47. BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways
48. Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture
49. Treatment prospects for autosomal-dominant polycystic kidney disease
50. Effects of epidermal growth factor and transforming growth factor-α on rabbit proximal tubule solute transport
51. Dissociation and reassociation of the phosphorylated and nonphosphorylated forms of adenosine 3′,5′-monophosphate-dependent protein kinase from bovine cardiac muscle
52. Growth characteristics of cells cultured from two murine models of polycystic kidney disease
53. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease
54. 8-Cl-cAMP induces truncation and down-regulation of the RI alpha subunit and up-regulation of the RII beta subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells
55. Cystic kidneys
56. Beta 2-adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein rap1 and the serine/threonine kinase B-Raf
57. Dynamic complexes of beta2-adrenergic receptors with protein kinases and phosphatases and the role of gravin
58. Characterization of PKA isoforms and kinase-dependent activation of chloride secretion in T 84 cells
59. Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase
60. Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease
61. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor 1
62. In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor
63. In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor
64. Structure, function, and regulation of human cAMP-dependent protein kinases
65. The RI subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor
66. The RI subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells
67. Cyclic AMP activates Ras
68. Peptide YY receptors in the proximal tubule PKSV-PCT cell line derived from transgenic mice. Relation with cell growth
69. Molecular basis of autosomal dominant polycystic kidney disease
70. Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex
71. Isoproterenol induces mitogenesis in MCT and LLC-PK 1 tubular cells
72. AVP inhibits EGF-stimulated MAP kinase cascade in Madin-Darby canine kidney cells
73. Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease
74. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway
75. A-kinase anchoring protein 100 (AKAP100) is localized in multiple subcellular compartments in the adult rat heart
76. Regulation of cAMP-dependent protein kinase: Enzyme activation without dissociation
77. Selectivity and regulation of A-kinase anchoring proteins in the heart. The role of autophosphorylation of the type II regulatory subunit of cAMP-dependent protein kinase
78. Regulation of PKA binding to AKAPs in the heart: Alterations in human heart failure